Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Alkem Laboratories Ltd. ( (IN:ALKEM) ).
Alkem Laboratories Ltd. has announced that its trading window for dealing in the company’s securities will be closed from 30 December 2025 until 48 hours after the financial results for the quarter and nine months ended 31 December 2025 are communicated to the stock exchanges. The move, undertaken in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct, is aimed at preventing insider trading and ensuring that all market participants have equal access to its upcoming financial information, reinforcing governance standards for investors and other stakeholders.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is a leading Indian pharmaceutical company engaged in the development, manufacturing and marketing of branded generics, generic drugs and active pharmaceutical ingredients, with a strong presence in domestic and international markets across key therapeutic segments.
Average Trading Volume: 5,619
Technical Sentiment Signal: Strong Buy
Current Market Cap: 665B INR
For detailed information about ALKEM stock, go to TipRanks’ Stock Analysis page.